Can clinicians distinguish cannabis-induced psychosis from schizophrenia? | Research

The takeaway

A study of 307 inpatients found that cannabis-induced psychosis patients had fewer negative symptoms, fewer auditory hallucinations, and more mania symptoms than schizophrenia patients, though no unique clinical pattern was identified; both cannabis-using groups had earlier first hospitalizations.

Clinicians differentiating cannabis-induced psychosis from schizophrenia, and researchers studying the overlap between these conditions.

First admission ~8 years earlier in cannabis groups

What the researchers found

Cannabis-induced psychosis (CIP) patients had lower negative PANSS scores (12.9 vs 17.2, p<0.001), fewer auditory hallucinations (60.3% vs 78.9%), and more mania (26.1% vs 12.3%, p<0.001) compared to schizophrenia with cannabis. Few differences existed between schizophrenia groups regardless of cannabis use. Both cannabis-using groups had earlier age of first psychotic admission (CIP: 26.1, SZ+CB: 25.3 vs SZ: 34.2, p<0.001).

Why it matters

Distinguishing cannabis-induced psychosis from primary schizophrenia has treatment implications. While no pathognomonic clinical pattern was found, the symptom profile differences (fewer negatives, more mania) may help clinicians consider CIP as a diagnosis.

The numbers in context

69 CIP, 57 SZ+CB, 181 SZ; CIP negative PANSS: 12.9 vs SZ: 17.2; auditory hallucinations: 60.3% vs 78.9%; mania: 26.1% vs 12.3%; age first admission: CIP 26.1, SZ+CB 25.3, SZ 34.2

How the study worked

Cross-sectional comparison of three inpatient groups: cannabis-induced psychosis (n=69), schizophrenia with cannabis (n=57), and schizophrenia without cannabis (n=181). The PRISM-IV scale differentiated induced psychosis. Symptoms assessed with PANSS.

What this study cannot tell us

Cross-sectional design. Single-site study. Retrospective diagnosis of cannabis-induced vs primary psychosis is inherently challenging. Different group sizes may affect statistical power.

How to read the evidence

Moderately sized clinical comparison using validated diagnostic instruments, but cross-sectional and single-site.

When this study was published

Published in 2021; the distinction between cannabis-induced and primary psychosis remains clinically challenging.

The bigger picture

The finding that cannabis-using groups had earlier first hospitalizations (by nearly a decade) strengthens the case that cannabis precipitates psychosis earlier in vulnerable individuals. The lack of clinical differences between schizophrenia groups (with and without cannabis) suggests that once schizophrenia develops, cannabis history may not alter the clinical picture.

Questions still open

Does cannabis-induced psychosis progress to schizophrenia in some patients, and if so, does the symptom profile shift? Could the mania component in CIP be a distinguishing feature for clinical decision-making? Would biomarkers help differentiate CIP from schizophrenia?

Common questions

Is cannabis-induced psychosis different from schizophrenia?

This study found CIP patients had fewer negative symptoms, fewer auditory hallucinations, and more manic features. However, no single clinical pattern was unique to CIP, making diagnosis challenging.

Does cannabis make psychosis happen sooner?

Both cannabis-using groups (whether CIP or schizophrenia with cannabis) were first hospitalized nearly a decade earlier than schizophrenia patients without cannabis use, supporting the idea that cannabis precipitates psychosis in vulnerable individuals.

Read the original research

Cannabis-induced psychosis: clinical characteristics and its differentiation from schizophrenia with and without cannabis use.

Adicciones, 33(2), 95-108

View on PubMed ↗Publisher’s paper ↗

Citation

Rentero, David; Arias, Francisco; Sánchez-Romero, Sergio; Rubio, Gabriel; Rodríguez-Jiménez, Roberto. (2021). Cannabis-induced psychosis: clinical characteristics and its differentiation from schizophrenia with and without cannabis use.. Adicciones, 33(2), 95-108. https://doi.org/10.20882/adicciones.1251